Personal Injury Attorneys – Atlanta, Georgia – Childers, Schlueter & Smith, LLC

TubePress

Dr. David Wetter, Mayo Clinic dermatologist, discu...

Cephalon has notified healthcare professionals abo...

Extrapyramidal side effect

Posted Feb 15, 2009 | Views 107

Childers & Schlueter Attorney C. Andrew Childers has been Interviewed Several Times About the Salmonella Outbreak http://www.candsfirm.com

Title: Stevens Johnson Syndrome-Mayo Clinic Proceedings
Views: 958
Posted: Aug 15, 2010
Description: Dr. David Wetter, Mayo Clinic dermatologist, discusses various features of Stevens-Johnson syndrome based on an article published in the February 2010 issue of Mayo Clinic Proceedings. http://tinyurl.com/yalgw7e

Title: Serious Skin and Hypersensitivity Reactions with Provigil
Views: 6,640
Posted: Aug 15, 2010
Description: Cephalon has notified healthcare professionals about new safety information for Provigil (modafinil). Provigil is used to reduce excessive sleepiness in adult patients with narcolepsy and other sleep disorders. Provigil is not approved for any indication in children. The revised labeling warns that Provigil can cause life-threatening skin reactions, including Stevens-Johnson Syndrome (SJS). Although benign rashes can also occur with this drug...

Title: Tardive Dyskinesia
Views: 92,540
Posted: Aug 15, 2010
Description: The Abnormal Involuntary Movement Scale (AIMSDVD.com)Training DVD is a unique resource for educators. It visually presents the AIMS exam & the entire range of "abnormal involuntary movement" associated conditions such as "tardive dystonia" using a representative range of actual patients. It scores the patients at each clips end, using the scores of a panel of medical practitioners expert in the AIMS exam. For more information go to www.AIMSDVD.co

Title: 20/20 Interview on DBS and Dystonia
Views: 11,785
Posted: Aug 15, 2010
Description: This is the 20/20 interview that features Ed Cwalinski's remarkable surgery called dbs that helped him with dystonia

Title: Warning on Metoclopramide (Reglan)
Views: 7,586
Posted: Jul 20, 2010
Description: FDA is requiring that manufacturers of metoclopramide add a boxed warning to the label about the risk of tardive dyskinesia if the drug is used for long periods of time or at high doses. Metoclopramide stimulates motility in the upper GI tract and its uses include diabetic gastroparesis and gastroesophageal reflux disease. Metoclopramide is marketed as a generic and under several trade names, including Reglan. Tardive dyskinesia is characterized...

Title: Stronger Warnings for Bowel Cleansing Agents
Views: 548
Posted: Jul 20, 2010
Description: FDA is announcing new safety measures for oral sodium phosphate (OSP) products used for bowel cleansing before colonoscopies and other procedures. These products are associated with acute phosphate nephropathy, a rare but serious type of kidney injury. The events have been reported with the prescription products Visicol and OsmoPrep, and also over-the-counter sodium phosphate products when they are used as bowel cleansers. FDA first warned a...

Title: FDA Drug Info Rounds, July 2010: Long-Acting Beta-Agonists (LABAs)
Views: 1,220
Posted: Jul 19, 2010
Description: Long-Acting Beta-Agonists (LABAs), a class of medications used for the treatment of asthma and chronic obstructive pulmonary disease (COPD), now have new recommendations in their drug label intended to promote their safe use in the treatment of asthma. The agency required manufacturers to revise their drug labels because of an increased risk of severe exacerbation of asthma symptoms, leading to hospitalizations, in pediatric and adult patients, a...

Title: Serious Skin Reactions in Asian Patients on Epilepsy Drugs
Views: 1,043
Posted: Jul 19, 2010
Description: FDA is investigating new preliminary data suggesting an increased risk of serious skin reactions from the anti-epileptic drugs phenytoin and fosphenytoin if they are taken by Asian patients who are positive for the human leukocyte antigen allele HLA-B*1502. These reactions include Stevens Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN). Phenytoin is marketed as Dilantin, Phenytek and generics. Fosphenytoin sodium is marketed as Cereby...

Title: Avoiding Medication Errors with Multiple Brand Names
Views: 3,700
Posted: Jul 19, 2010
Description: The Institute for Safe Medication Practices (ISMP) recently highlighted medication errors that can occur when a drug is marketed under more than one brand name, especially when one of those names is well established. ISMP describes a case where a female patient went to the emergency department with ischemic chest pain and ECG changes. One of her medications was Revatio, which had been prescribed to treat her pulmonary arterial hypertension. ...

Title: Antiepileptic Drugs and Suicidality
Views: 920
Posted: Jul 19, 2010
Description: FDA is alerting healthcare professionals that the labeling for antiepileptic drugs will now warn that patients taking these drugs have an increased risk of suicidal thoughts and actions. The warnings are based on FDA's analysis of placebo-controlled clinical studies of eleven drugs used to treat epilepsy, psychiatric disorders and other conditions. In this analysis, the risk was approximately doubled in patients receiving the anti-epileptic d...

Title: Food Allergies: Reducing the Risk (Consumer Update)
Views: 4,016
Posted: Jul 19, 2010
Description: This FDA Consumer Update video highlights how FDA is working to ensure that allergens in food are clearly and accurately labeled.

prev12 3 next